Fundz

Who to call at GRI Bio, Inc., and when

Fundz watches for the moments GRI Bio, Inc. starts buying, and tells you who to reach.

  • An alert the day GRI Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GRI Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GRI Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

GRI Bio, Inc.

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

gribio.com
Filed: Nov 4, 2026LA JOLLA, CaliforniaCIK: 0001824293Biotechnology
Full company profileView on SEC.gov

Executive Summary

Analysis of 8-K filing content

GRI Bio, Inc. held its 2026 Annual Meeting on November 4, 2026, electing two new Class III directors (W. Marc Hertz, Ph.D. and David Szekeres) and approving a significant amendment to its 2018 Equity Incentive Plan that increases reserved shares by 546,529 and extends the evergreen provision to January 1, 2036.

Quick answer

GRI Bio, Inc. filed a Form 8-K with the SEC on November 4, 2026 under Item 5.02 (Executive Change). GRI Bio, Inc. held its 2026 Annual Meeting on November 4, 2026, electing two new Class III directors (W. Marc Hertz, Ph.D. and David Szekeres) and approving a significant amendment to its 2018 Equity Incentive Plan that increases reserved shares by 546,529 and extends the evergreen provision to January 1, 2036.

What did GRI Bio, Inc. disclose in its 8-K filed November 4, 2026?
GRI Bio, Inc. held its 2026 Annual Meeting on November 4, 2026, electing two new Class III directors (W. Marc Hertz, Ph.D. and David Szekeres) and approving a significant amendment to its 2018 Equity Incentive Plan that increases reserved shares by 546,529 and extends the evergreen provision to January 1, 2036.
What does 8-K Item 5.02 (Executive Change) mean?
A senior executive or director joined, left, or changed roles. Companies generally must file it within four business days of the event.
Which other companies filed an 8-K Item 5.02 around the same time?
Noble Corporation plc (November 4, 2026), Thunder Mountain Gold, Inc. (November 4, 2026), Penguin Solutions, Inc. (November 4, 2026) and Siebert Financial Corp. (November 4, 2026) also filed an Item 5.02 8-K within a week of GRI Bio, Inc.
Where can I read the original GRI Bio, Inc. filing?
The original filing is on SEC EDGAR (CIK 0001824293), accession number 0001824293-26-000063.

Source: Fundz verified event record.

Other companies that filed an 8-K Item 5.02 (Executive Change) the same week

Analyzed filings with the same item number within 7 days, from SEC EDGAR via Fundz.

  • Noble Corporation plc (November 4, 2026): Noble Corporation promoted Joey M. Kawaja from Senior Vice President of Operations to Executive Vice President and Chief Operating Officer effective November 1, 2026, signaling a...
  • Thunder Mountain Gold, Inc. (November 4, 2026): Thunder Mountain Gold appointed Dr. Steven A. Osterberg as Senior Vice-President of Exploration effective September 8, 2026, while accepting the resignation of Chief Operating...
  • Penguin Solutions, Inc. (November 4, 2026): Penguin Solutions agreed to sell its Cree LED/Optimized LED business to Transom Crystal AcquireCo, LLC in an all-cash transaction expected to close in Q1 2027.
  • Siebert Financial Corp. (November 4, 2026): Siebert Financial Corp. appointed Richard S. Gebbia and David J. Gebbia as Co-Chief Executive Officers effective November 4, 2026, with John J. Gebbia transitioning to Chairman.
  • Childrens Place, Inc. (November 4, 2026): Multiple executive departures at Children's Place, Inc. occurred in early November 2026, including the resignation of President and Interim CEO Muhammad Asif Seemab and Chief...
  • Electronic Servitor Publication Network, Inc. (November 4, 2026): Thomas Spruce resigned on October 29, 2026, from his positions as Director, COO, CFO, and Secretary of Electronic Servitor Publication Network, Inc. Peter Hager, the current...

Key Takeaways

Two new directors elected to serve until 2029 Annual Meeting, signaling board refreshment and potential strategic direction changes

Equity Incentive Plan amended to increase share reserve by 546,529 shares and extend evergreen provision to 2036, indicating expanded compensation capacity

1 more takeaway

Related Filings (1)

1 more filing from GRI Bio, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateNov 4, 2026
Item5.02
CategoryExecutive Change
CIK0001824293
Accession #0001824293-26-000063
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

GRI Bio, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.